N
Minerva Neurosciences, IncNERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva's goal is to transform the lives of patients with improved therapeutic options, including roluperidone for negative symptoms of.
US StocksHealthcareSmall CapBiotechnologyGrowth Stocks
NERV の価格トレンド
Minerva Neurosciences, Inc · TradingView フルチャート
NASDAQ:NERV